$4 a share would be a 440m market cap
With a fully funded Phase 1 trial of NB1222/NB1111 and then positive results, we would be Off to the races. Look at $ZYNE at its Peak , much higher
And Look at GW. SPent a Lot of time on their first drug that WILL NEVER get approved in the USA as a medicine. Maybe one day as a rec product. And now a new Drug in Phase 3 trials, when asked about the science of your manufacturing you give toss a word salad and conclude with 'sorry about unscientific answer', and now doubt about whether the benefit of CBD is directly from the molecule or an interaction with other epilepsy drugs.
Still 1B market cap.
I have them Right between the eyes, whether they know it or not
And I hope $ZYNE goes higher but some People are probably pretty mad at Management
I'm not short either and wish them Good luck